Remimazolam vs. Midazolam for sedation during upper GI endoscopy
Treatments studied
Part of Digestive system clinical trials.
This study compares two different sedative medicines, remimazolam and midazolam, to see which works better for people having a routine upper GI endoscopy (a camera test to look at your stomach and esophagus). If you are scheduled for this procedure and need sedation, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled for a routine upper GI endoscopy (a camera test for your stomach) with sedation.
- You are able to understand what the study involves and give your written permission.
- You will not be given strong pain medicine (opioids) during the procedure.
- You do not have a severe health condition (ASA score of 4) that limits your daily activities.
- You do not have an ongoing drug or alcohol problem that would affect your understanding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remimazolam, a newer sedative, works as well as midazolam (a common sedative) for keeping patients comfortable during endoscopy procedures that examine the stomach and pancreas. The study aims to see which medication has fewer side effects.
This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.
This trial compares two sedative medications, remimazolam and midazolam, to see which works better and is safer for deeply sedating adults on breathing machines who have unstable blood pressure. It may help doctors choose a sedation option that causes fewer drops in blood pressure.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This trial compares two sedatives, remimazolam and midazolam, to see which one leads to better recovery of thinking skills after orthopedic surgery. It is for people aged 65 and older who are having surgery on a bone or joint while awake but relaxed.
Hear when a new Sedation for Diagnostic Gastroscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.